CSNK1A1 and colonic neoplasm: With regard to the potential future use of CK1 isoform-specific inhibitors in therapeutic strategies for cancer treatment, the influence of compounds 20, 21, and 22 on cell viability of various established colon cancer cell lines was tested by performing MTT viability assays.